Hong Kong · Delayed Price · Currency is HKD Keymed Biosciences Statistics
Total Valuation
HKG:2162 has a market cap or net worth of HKD 22.91 billion. The enterprise value is 19.98 billion.
| Market Cap | 22.91B |
| Enterprise Value | 19.98B |
Important Dates
The last earnings date was Wednesday, August 19, 2026.
| Earnings Date | Aug 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:2162 has 294.60 million shares outstanding. The number of shares has increased by 8.53% in one year.
| Current Share Class | 294.60M |
| Shares Outstanding | 294.60M |
| Shares Change (YoY) | +8.53% |
| Shares Change (QoQ) | +7.31% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 37.05% |
| Float | 219.45M |
Valuation Ratios
The trailing PE ratio is 24.88 and the forward PE ratio is 50.62.
| PE Ratio | 24.88 |
| Forward PE | 50.62 |
| PS Ratio | 23.77 |
| PB Ratio | 4.95 |
| P/TBV Ratio | 4.97 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 22.38 |
| EV / Sales | 20.74 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.83, with a Debt / Equity ratio of 0.17.
| Current Ratio | 4.83 |
| Quick Ratio | 4.21 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -42.93 |
Financial Efficiency
Return on equity (ROE) is 21.49% and return on invested capital (ROIC) is -33.51%.
| Return on Equity (ROE) | 21.49% |
| Return on Assets (ROA) | -8.24% |
| Return on Invested Capital (ROIC) | -33.51% |
| Return on Capital Employed (ROCE) | -14.00% |
| Weighted Average Cost of Capital (WACC) | 3.43% |
| Revenue Per Employee | 592,958 |
| Profits Per Employee | 549,635 |
| Employee Count | 1,625 |
| Asset Turnover | 0.16 |
| Inventory Turnover | 0.87 |
Taxes
In the past 12 months, HKG:2162 has paid 333.52 million in taxes.
| Income Tax | 333.52M |
| Effective Tax Rate | 27.18% |
Stock Price Statistics
The stock price has increased by +8.56% in the last 52 weeks. The beta is -0.14, so HKG:2162's price volatility has been lower than the market average.
| Beta (5Y) | -0.14 |
| 52-Week Price Change | +8.56% |
| 50-Day Moving Average | 75.07 |
| 200-Day Moving Average | 63.95 |
| Relative Strength Index (RSI) | 55.63 |
| Average Volume (20 Days) | 2,358,970 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:2162 had revenue of HKD 963.56 million and earned 893.16 million in profits. Earnings per share was 3.13.
| Revenue | 963.56M |
| Gross Profit | 762.08M |
| Operating Income | -784.23M |
| Pretax Income | 1.23B |
| Net Income | 893.16M |
| EBITDA | -689.23M |
| EBIT | -784.23M |
| Earnings Per Share (EPS) | 3.13 |
Balance Sheet
The company has 3.73 billion in cash and 804.31 million in debt, with a net cash position of 2.92 billion or 9.92 per share.
| Cash & Cash Equivalents | 3.73B |
| Total Debt | 804.31M |
| Net Cash | 2.92B |
| Net Cash Per Share | 9.92 |
| Equity (Book Value) | 4.63B |
| Book Value Per Share | 16.30 |
| Working Capital | 3.61B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 95.97M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 79.09%, with operating and profit margins of -81.39% and 92.69%.
| Gross Margin | 79.09% |
| Operating Margin | -81.39% |
| Pretax Margin | 127.33% |
| Profit Margin | 92.69% |
| EBITDA Margin | -71.53% |
| EBIT Margin | -81.39% |
| FCF Margin | n/a |
Dividends & Yields
HKG:2162 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.53% |
| Shareholder Yield | -8.53% |
| Earnings Yield | 3.90% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for HKG:2162 is 100.08, which is 25.58% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 100.08 |
| Price Target Difference | 25.58% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (3Y) | 60.06% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |